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The in‐depth understanding of skin resident memory CD8+ T lymphocytes (TRM) may help to 
uncover strategies for their manipulation during disease. We investigated isolated TRM from healthy 
human skin, which expressed the residence marker CD69, and compared them to circulating CD8+ 
T cell populations from the same donors. There were significantly increased proportions of 
CD8+CD45RA–CD27– T cells in the skin that expressed low levels of killer cell lectin‐like receptor 
G1 (KLRG1), CD57, perforin and granzyme B. The CD8+ TRM in skin were therefore phenotypically 
distinct from circulating CD8+CD45RA–CD27– T cells that expressed high levels of all these 
molecules. Nevertheless, the activation of CD8+ TRM with T cell receptor (TCR)/CD28 or interleukin 
(IL)‐2 or IL‐15 in vitro induced the expression of granzyme B. Blocking signalling through the 
inhibitory receptor programmed cell death 1 (PD)‐1 further boosted granzyme B expression. A 
unique feature of some CD8+ TRM cells was their ability to secrete high levels of tumour necrosis 
factor (TNF)‐α and IL‐2, a cytokine combination that was not seen frequently in circulating CD8+ T 
cells. The cutaneous CD8+ TRM are therefore diverse, and appear to be phenotypically and 
functionally distinct from circulating cells. Indeed, the surface receptors used to distinguish 
differentiation stages of blood T cells cannot be applied to T cells in the skin. Furthermore, the 
function of cutaneous TRM appears to be stringently controlled by environmental signals in situ. 
  





T cells are abundant in healthy human adult skin and are an important component of the local 
immune system 1, 2. Tissue resident T cells (TRM) arise from naive precursors that are first activated 
in secondary lymphoid organs and then migrate to the peripheral tissues, where they are retained 
through expression of CD69 and may act as sentinels for future reinfection 3-5. Current literature 
suggests that TRM may have constitutive functional activity and are poised to respond rapidly to 
antigenic challenge 1, 2. However, the mechanisms controlling the effector functions of these cells, 
particularly their cytotoxic function, are not known. 
 
There has been extensive characterization of surface markers that can be used to identify circulating 
T cells at different stages of differentiation 6, 7. The correlation between phenotype and function has 
enabled the discrimination between naive (TN; CD45RA+CD27+), central memory (TCM; 
CD45RA+CD27+), effector memory (TEM; CD45RA‐CD27‐) and effector memory T cells that re‐
express CD45RA (TEMRA; CD45RA+CD27‐) within both CD4+ and CD8+ T cell subsets 7, 8. In 
peripheral blood, highly differentiated TEM and TEMRA cells display high constitutive levels of 
preloaded cytotoxic granules containing perforin and granzyme B and can secrete the effector 
cytokines tumour necrosis factor (TNF)‐α and interferon (IFN)‐γ after activation in vitro 7. In addition 
these cells have short telomeres 9-11, lack the co‐stimulatory receptors CD27 and CD28, cannot 
produce the cytokine interleukin (IL)‐2 but express high levels of CD57 and the inhibitory receptor 
killer cell lectin‐like receptor G1 (KLRG1) 7, 11, 12. These circulating cells also express high levels of 
the transcription factors T‐bet and Eomesodermin (Eomes), that are important for cytotoxic 
differentiation 13. Overall, TEM and TEMRA are thought to have gained increased effector 
capabilities at the expense of proliferative activity compared to TN and TCM cells 7, 11, 12. Unlike TN 
and TCM cells, the TEM and TEMRA populations do not home to lymphoid tissues, but may migrate 
instead to peripheral organs, including the skin 14, 15. Because most TRM in the skin lack the lymph 
node homing receptor C‐C chemokine receptor type 7 (CCR7), they were thought initially to belong 
to the same lineage as TEM in the blood 1, 16. However, the mechanisms that control the activity of 
skin TRM in situ and their phenotype are poorly defined. 





The aim of this study was to investigate the cytotoxic potential of CD8+ TRM in the skin of healthy 
donors and to identify the factors that influence the function of these cells. We found that CD8+ TRM 
are not poised for immediate cytotoxic activity, as they contain very low levels of perforin and 
granzyme B relative to effector CD8+ T cells in the blood. CD8+ TRM cells require cytokine‐ or T cell 
receptor (TCR)‐mediated activation in order to adopt a cytotoxic effector phenotype, while inhibitory 
signalling though programmed cell death 1 (PD‐1) may prevent this. In addition, phenotypical 
markers that identify highly differentiated cells in the blood (KLRG1, CD57, CD28–) are not 
characteristics of EM (CD27–CD45RA–) or EMRA (CD27–CD45RA+) TRM cells in the skin. Therefore, 
the correlation of differentiation stage of CD8+ T cell subsets with surface phenotype, which has 
been used widely to characterize circulating cells, cannot be extrapolated to the study of TRM 
populations in the skin. Instead, the skin appears to be populated with phenotypically distinct and 
diverse quiescent T cells, including a novel CD8+ T cell subset capable of producing both IL‐2 and 
TNF‐α upon stimulation. 
  




Material and methods 
Blood and skin samples 
Blood, skin and blister samples were obtained from healthy donors or individuals undergoing plastic 
surgery. Individuals suffering from co‐morbidities or on medication were excluded from the study. 
We investigated 33 skin donors in total (average age: 46 years, age range = 19–82, four males, 29 
females). Written and informed consent was obtained from all participants, in agreement with the 
declaration of Helsinki protocols, and the study was approved by the Ethics Committee of the Royal 
Free Hospital and Guy’s Hospital, London. 
 
Sample preparation 
Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation using Ficoll‐
Paque PLUS (GE Healthcare, Little Chalfont, UK). Cutaneous single‐cell suspensions were obtained 
by overnight digestion of finely minced skin specimen with 0·8 mg/ml collagenase type IV (Life 
Technologies, Paisley, UK) in RPMI. Addition of 20% fetal calf serum (FCS) to the digestion mix 
prevented surface receptor degradation 17. The cells from digested skin showed negligible surface 
marker degradation and similar phenotypical properties to those analysed in snap‐frozen skin 
sections in situ via immunofluorescence, as reported previously 18. Skin cells were obtained as 
described previously from suction blisters raised on normal skin 19. 
 
Flow cytometry 
Antibodies used for flow cytometry are summarized in Supporting information, Table S1. Single‐cell 
suspensions were stained initially for extracellular markers, followed by intracellular staining 
according to the manufacturers’ instructions using either the Fix & Perm Cell Permeabilization Kit 
(An Der Grub, Buckingham, UK) for cytokines, perforin and granzyme B or intranuclear forkhead box 
protein 3 (FoxP3) Staining Buffer Set (Miltenyi Biotec, Bisley, UK) for T‐bet and Eomes staining. To 
assess cytokine production, cells were stimulated with 25 ng/ml phorbol myristate acetate (PMA) 
and 500 ng/ml ionomycin for 1 h, followed by addition of 5 μg/ml brefeldin A (Sigma‐Aldrich, Poole, 
UK) and incubation for a further 5 h. Unstimulated cells were used as the negative control. Telomere 




lengths were measured via flow cytometry using the flow‐fluorescence in‐situ hybridization (FISH) 
method, as described previously 9. Pooled samples of blood and carboxyfluorescein succinimidyl 
ester (CFSE)‐stained blister cells were used for the flow‐FISH method in order to ensure equivalent 
staining between both cell populations. All samples were acquired using LSRII or Fortessa flow 
cytometers (both from BD Biosciences, San Jose, CA, USA) and analysed using FlowJo (TreeStar 
Inc., Ashland, OR, USA). 
 
Immunofluorescence 
Punch biopsies (5 mm diameter) from normal skin were frozen in optimal cutting temperature 
compound (OCT; Bright Instrument Company Ltd, Luton, UK); 6 μm sections were cut, left to dry 
overnight, then fixed in ethanol and acetone and stored at –80ºC. Samples were incubated with 
optimal dilutions of primary antibodies followed by an appropriate secondary antibody conjugated to 
various fluorochromes, as described 18. Antibodies used were: CD69 (clone FN50; Biolegend, San 
Diego, CA, UK), CD103 (clone 2G5.1; Thermo Fisher Scientific, Waltham, MA, USA), CD8 (clone 
RPTA‐T8; BD Bioscience, San Jose, CA, USA), CD4 (YNB46.1.8; BD Bioscience) and PD‐1 (clone 
NAT105; Abcam, Cambridge, UK). Images were acquired on the AxioScan Z1 slide scanner and 
Imaged on Zen Blue (Zeiss, Cambridge, UK). 
 
Culture conditions 
Cells were maintained in RPMI with 10% FCS, 1% penicillin/streptomycin and 1% L‐glutamine (all 
by Sigma‐Aldrich). PBMCs or cells derived from collagenase digested skin were incubated for 4 days 
in the presence of no stimulant, 10 ng/ml TNF‐α, 5 ng/ml IL‐2 (both PeproTech, London, UK), 10 
ng/ml IL‐15 (R&D Systems, Abingdon, UK) or anti‐CD3/CD28 coated beads (Dynabeads; Life 
Technologies, Paisley, UK), followed by flow cytometric staining. For PD‐1 signalling blockade, cells 
were incubated with 10 mg/ml of anti‐PD‐1 ligand (PDL)‐1 and anti‐PDL‐2 antibodies (MIH1 and 
MIH18) or 20 mg/ml isotype control (all eBioscience, Sa Diego, CA, USA) for 2 h prior to stimulation 
with 0·05 μg/ml immobilized anti‐CD3 (OKT3) for 3 days. 
 





Graphs were drawn and statistical analysis was performed using GraphPad Prism version 5 
(GraphPad Software, San Diego, CA, USA). Non‐parametric data were identified using the 
D’Agostino and Pearson omnibus normality test. Statistical tests used included the Student’s t‐test 
or paired t‐test when data followed a Gaussian distribution and the Mann–Whitney U‐test or 
Wilcoxon’s test for non‐parametric data. Correlations were calculated using Pearson’s correlation 
coefficient or Spearman’s correlation for non‐parametric data. Lines of best fit were generated using 
linear regression. If more than two groups were compared simultaneously, one‐way analysis of 
variance (anova) (for parametric data) or the Friedman test (for non‐parametric data) were applied, 
followed by Holm–Sidak or Dunn’s multiple comparison tests, respectively, for paired comparisons. 
Differences were considered significant when P < 0·05. 
  





Skin‐derived CD8+ TRM cells express CD69 and are enriched for CD27–CD45RA– (effector 
memory‐like) populations  
Single‐cell suspensions were generated through overnight collagenase digestion of fresh healthy 
human skin and CD8+ T cell phenotype was analysed at the same time as PBMCs from the same 
healthy donors (representative gating strategy in Fig. 1a). The majority of skin but not blood‐derived 
CD8+ T cells expressed CD69 that identifies them as tissue resident T cells 20 (Fig. 1b–d). In the 
blood, combined use of the surface markers CD27 and CD45RA allows the identification of CD8+ T 
cells that have functional characteristics of naive (CD45RA+CD27+), TCM (CD45RA–CD27+), TEM 
(CD45RA–CD27–) and late stage/senescent TEMRA (CD45RA+CD27–) cells 7,21. Among skin CD8+ 
T cells, the relative expression of CD45RA and CD27 identified four subsets as found in blood (Fig. 
1e,f). However, skin CD8+ T cells were enriched significantly for the CD45RA–CD27– T subset, while 
the CD45RA+CD27+ subset was reduced significantly in this tissue (Fig. 1e,f). Among the skin CD8+ 
T cells, CD69 expression was equally high in all four subsets (Fig. 1g). Similar changes were also 
observed in CD4+ T cells, where skin cells were mainly CD69+ and were enriched for CD45RA–
CD27– T cells compared to the blood of the same donors (Supporting information, Fig. S1a,b).  
 
Skin CD8+ TRM cells exhibit distinct expression of differentiation‐associated surface markers 
compared to blood T cells  
We next investigated whether skin CD8+ TRM cells had the same phenotypical properties as their 
circulating counterparts. Circulating CD8+CD45RA–CD27– and CD8+CD45RA+CD27– T cells have 
been shown to express low levels of CD28 but high levels of the natural killer (NK) cell‐associated 
receptors KLRG1 and CD57 compared to less differentiated populations 11, 22, 23. Total skin CD8+ TRM 
expressed similar levels of CD28 and CD57 but significantly lower levels of KLRG1 compared to the 
total circulating CD8+ T cell population (Fig. 2). However, when comparing the two tissues’ 
CD8+CD45RA+CD27– subsets, CD28 expression was significantly higher while CD57 and KLRG1 
expression were significantly lower in the skin (Fig. 2). In addition, the CD8+CD45RA+CD27+ TRM 
cells in the skin expressed significantly lower levels of CD28 and higher levels of CD57 than this 




subset in the blood. Similar patterns were observed in skin CD4+ T cells, where the dominant 
CD45RA–CD27+ population did not express KLRG1 (Supporting information, Fig. 1). These results 
suggest that patterns of differentiation differ between blood and skin T cells.  
 
To test the possibility that the CD8+ T cells in the skin and the circulation have disparate expression 
of differentiation‐related markers because of differences in their replicative history, we compared the 
telomere lengths of these cells. In peripheral blood, CD8+CD45RA+CD27+ T cells have the longest 
and CD8+CD45RA–CD27– T cells the shortest telomeres among T memory cell subsets 24. As debris 
present in digested skin samples interfered with telomere detection, we isolated CD8+ TRM cells by 
suction blister technology 25 and compared them to circulating populations from the same donors 
(representative gating strategy shown in Supporting information, Fig. 2). Naive T cells had longer 
telomeres than CD45RA–CD27– (TEM) and CD45RA+CD27– T (TEMRA) subsets in both skin and blood 
CD8+ T cells (Fig. 2). Furthermore, telomere length of blood and skin total CD8+ T cells and there 
were similar (8.9 ± 1·8 kbp in the skin and 9·7 ± 2 kbp in blood CD8+ T cells; Fig. 2d). This indicated 
that the altered expression of differentiation‐related markers between CD8+ TRM and their blood 
counterparts was not due to differences in replicative history. However, telomere length was reduced 
significantly in skin compared to blood in total CD4+ T cells (8·0 ± 1·0 kbp in the skin versus 
10·3 ± 1·8 kbp in the blood, Supporting information, Fig. 2b), indicating that skin CD4+ TRM cells have 
experienced more proliferation in vivo.  
 
A unique population of skin CD8+ TRM secretes IL‐2 and TNF‐α after activation in vitro 
Cutaneous CD8+ TRM are considered a first line of defence against reinfection by pathogens 2, 26. We 
investigated differences in cytokine production between isolated CD8+ TRM and circulating CD8+ T 
cells. The production of three cytokines, IL‐2, TNF‐α and IFN‐γ, individually or in combination, was 
measured after stimulation with PMA and ionomycin in vitro (Fig. 3). Among peripheral blood T cells, 
different subsets secrete either IL‐2 alone or TNF‐α together with IFN‐γ 23. In the skin, we observed 
a reduction in cells producing IL‐2 alone and an increase in novel populations of CD8+ T cells, which 
lacked IFN‐γ but secreted either TNF‐α alone or in combination with IL‐2 (Fig. 3b). CD8+ TRM that 




secreted both IL‐2 and TNF‐α were not confined to one particular CD45RA/CD27 population (Fig. 
3c).  
 
The average abundance of CD8+ T cells that secreted all three cytokines together after activation 
was not significantly different between blood and skin samples (Fig. 3b). However, slight but not 
significant differences were noted in the distribution of these multiple cytokine producers among the 
CD45RA+CD27– subsets (Fig. 3d). These data indicate that the functional profiles of CD8+ T cells 
and their CD45RA/CD27 subsets are distinct in the blood and skin, and that the skin may contain 
unique populations of cells with different functional properties.  
 
CD8+ TRM in normal skin have low cytotoxic potential  
CD8+ TRM cells are considered to be poised for rapid responses in case of pathogen re‐encounter 26. 
Previous work from our group has shown that the TEM and TEMRA T cell subsets in the blood contain 
preloaded cytotoxic granules containing perforin and granzyme B 11, 23. Here, we show that the levels 
of both proteins were consistently lower in skin CD8+ T cells compared to the same subsets in blood, 
with perforin being almost undetectable in most individuals (Fig. 4). Furthermore, perforin and 
granzyme B levels were low in the CD8+CD45RA–CD27– and CD8+CD45RA+CD27– T cell subsets in 
the skin while being particularly high in the equivalent populations in the blood (Fig. 4c).  
 
We next investigated whether the low cytotoxic mediator expression was induced locally in the skin 
or whether this was predetermined in T cells with skin homing potential. To do this we examined 
perforin and granzyme B expression in circulating T cells expressing the cutaneous lymphocyte 
antigen (CLA; Fig. 4d). Blood‐derived CD8+CLA+ T cells expressed significantly less perforin and 
granzyme B than the CLA– population (Fig. 4d), suggesting that cutaneous T cells lack cytotoxic 
effector functions prior to populating the skin.  
 
Among skin‐derived T cells, true resident cells express both CD103 and CD69 while cells 
transitioning in the tissue do not express either surface receptor 20. We found that among skin CD8+ 




T cells granzyme B expression was highest in the minor ‘transitioning’ CD69–CD103– population and 
lowest in the ‘true resident’ CD69+CD103+ population and that perforin was low in all these subsets 
(Fig. 4e). Furthermore, the transcription factors T‐bet and Eomes, which are associated with effector 
memory T cell populations 13, were both absent among CD8+ TRM cells, even among those that were 
granzyme B‐positive (Fig. 4f). Therefore, unlike circulating CD8+ T cells, CD8+ TRM in healthy skin do 
not have a conventional effector phenotype and these cells lack immediate cytotoxic potential.  
 
Surface markers that correlate with cytotoxic potential in circulating CD8+ T cells are not 
applicable in the skin  
In the published literature, blood effector memory T cells are identified by their effector functions 
together with the increased expression of surface markers such as KLRG1 and the absence of other 
receptors, such as CD27 or CD28 7. We confirmed a strong positive correlation between KLRG1 
expression and granzyme B expression (Fig. 5a) and a negative correlation between both CD27 
(Fig. 5b) and CD28 (Fig. 5c) with granzyme B expression in blood CD8+ T cells. This was not 
observed in cutaneous CD8+ TRM cells. There is therefore a dissociation between the expression of 
this cluster of phenotypical markers and effector function of skin CD8+ TRM cells, indicating further 
that memory CD8+ T cells from the circulation and the skin are controlled differently.  
 
Cutaneous CD8+ TRM skin T cells can be induced to express perforin and granzyme in vitro 
Circulating CD8+ T cells can up‐regulate perforin and granzyme B after stimulation 27, 28. In order to 
investigate whether skin‐derived CD8+ T cells also have the ability to acquire cytotoxic potential, we 
activated total TRM and PBMCs in vitro with or without either TNF‐α , IL‐2, IL‐15 or anti‐CD3/CD28 
antibody‐coated beads. After 4 days, perforin and granzyme B expression were measured via 
intracellular flow cytometry (Fig. 6a). All these stimulants, apart from TNF‐α , induced a significant 
increase in granzyme B in both blood and skin CD8+ T cell populations (Fig. 6a). Perforin levels were 
increased significantly in both blood and skin CD8+ T cells by IL‐15 or CD3/CD28 stimulation (Fig. 
6a). Skin CD8+ TRM cells are therefore capable of up‐regulating their cytotoxic machinery to the same 
extent as blood populations, suggesting that these cells are not inherently unresponsive.  




PD‐1 signalling may be involved in low cytotoxic potential of skin T cells 
PD‐1 is a regulatory surface receptor often implicated in peripheral tolerance, and we hypothesized 
that PD‐1 signalling may control granzyme B and/or perforin expression in skin TRM cells. PD‐1 levels 
were low among circulating CD8+ T cells but significantly higher in skin CD8+ TRM cells (Fig. 6). PD‐
1 staining of TRM was confirmed by immunohistology (Fig. 6d). To test whether PD‐1 signalling affects 
perforin and granzyme B expression, healthy skin‐derived cells were stimulated with suboptimal 
levels of plate‐bound anti‐CD3 antibody. This was performed in the presence of PD‐L1 and PD‐L2 
blocking antibodies or isotype controls. In the presence of PD‐1 ligand blockade, intracellular perforin 
was only increased significantly in blood‐derived CD8+ T cells but not in skin‐derived cells, while 
granzyme B was increased significantly compared to the isotype control in CD8+ T cells from both 
tissues (Fig. 6e). Therefore, while PD‐1 signalling may contribute partially to the inhibition of cytotoxic 
potential of CD8+ TRM in the skin, other mechanisms are also likely to be involved.  
  





A major advance in the understanding of immune memory was the recognition that memory T cells 
in tissues are an important barrier to reinfection and reactivation of pathogens 26. Circulating T cells 
and TRM cells have different transcriptional profiles, suggesting that their activity is differentially 
controlled 4, 5. However, the mechanisms involved have not been defined. The aim of the present 
study was to compare the functional activity and extent of phenotypical differentiation of skin CD8+ 
T cells to those in the blood in healthy humans.  
 
Blood‐derived T cell subsets with distinct differentiation and functional properties are often identified 
through well‐defined surface markers such as CD27 and CD45RA 7. We found that almost all skin‐
derived CD8+ T cells expressed the tissue retention marker CD69, identifying them as TRM 29. Among 
them, those that were CD45RA–CD27– and CD45RA+CD27– displayed low levels of perforin and 
granzyme B, substantially reduced expression of KLRG1 and CD57 and lacked the transcription 
factors T‐bet and Eomes, but secreted both IL‐2 and TNF‐α after activation. This is clearly distinct 
from equivalent phenotypically defined CD8+ T cells in the circulation that have high perforin, 
granzyme, KLRG1, CD57, Eomes and T‐bet and secrete TNF‐α and IFN‐γ, but no IL‐2. Other studies 
using mRNA as a readout also report low levels of perforin, granzyme B or Eomes mRNA in healthy 
skin of humans or mice 5, 30. This indicates that the correlation between effector phenotype and 
function that is observed in blood CD8+ T cells cannot be extrapolated to CD8+ TRM populations, and 
a similar situation exists for CD4+ TRM populations. Stated simply, cutaneous CD45RA+CD27+ CD8+ 
TRM are not naive and CD8+CD45RA–CD27– TRM cells are not immediately operational effector‐like 
cells, unlike their blood counterparts.  
 
Circulating cells expressing the skin homing marker CLA also lacked perforin and granzyme B, 
suggesting that the low cytotoxic potential of TRM is pre‐programmed in CD8+ T cells with a propensity 
for homing to the skin. Instead, we found that some cutaneous CD8+ TRM cells can up‐regulate their 
cytotoxic machinery after activation. Furthermore, cytotoxic T cells can be found in inflamed skin in 
patients with atopic dermatitis, psoriasis, herpes simplex‐2 infection and vitiligo 2, 31, 32. This suggests 




that some T cells can become cytotoxic within the skin under appropriate stimulatory conditions in 
vivo and is in line with a recent report showing that among stimulated epidermal TRM, one specific 
subset of CD49a+ cells is able to up‐regulate cytotoxic effector molecules 32. This, together with our 
observation that TRM share few phenotypical characteristics with highly differentiated cells in the 
blood, also supports previous murine work showing that skin TRM can extensively proliferate locally 
and are derived from less differentiated circulating KLRG1– memory precursor T cells 5, 33.  
 
We observed that the inhibitory receptor PD‐1 was significantly higher on skin TRM cells compared 
to CD8+ T cells in the circulation. Subsequent blockade of PD‐1 signalling during TCR stimulation in 
vitro resulted in increased granzyme B but not perforin expression in the skin CD8+ TRM cells, 
suggesting that other mechanisms may be involved in the repression of cytotoxic granule expression 
in skin CD8 TRM. Granzyme B can cause extracellular matrix degradation 34 and PD‐1 signalling may 
therefore be involved in limiting CD8+ T cell‐mediated tissue damage. PD‐1 is reportedly elevated 
on brain, gastric mucosa and liver T cells 35-37, suggesting that PD‐1 signalling may also be important 
in limiting the activity of resident CD8+ T cells in other tissues.  
 
Cytokines produced by activated skin TRM may also influence local immune responses. Large 
clusters of infiltrating T cells associated with a cytotoxic gene signature appear rapidly in human skin 
during challenge with varicella‐zoster virus (VZV) antigens after vaccination against herpes zoster 
38, 39. We suggest that, after activation, a subset of CD8+ TRM, with their unique cytokine secreting 
profile (IL‐2+TNF‐α +), may activate endothelial cells through TNF‐α 40, thereby promoting the 
recruitment of cells from the circulation. Further IL‐2 secretion by these cells would promote the 
expansion of the recruited cells at the site of challenge in the skin. Given that T cells expressing the 
skin‐homing receptor CLA did not express perforin or granzyme B readily either, it is likely that 
recruited cells also may require further local stimulation to convert to a cytotoxic phenotype. Indeed, 
the importance of local effector T cell licensing in the skin was demonstrated in a murine graft‐versus‐
host model, where T cell infiltration into the skin graft was not sufficient for rejection but required 
local Langerhans‐mediated help for T cell cytotoxicity towards the mismatched graft 41.  




Although skin resident CD8+ TRM uniformly expressed CD69 and lacked perforin, our data also 
indicate heterogeneity among these cells in terms of cytokine production and expression of surface 
receptors such as CD27, CD28 CD45RA, KLRG1 and CD57. This suggests that similarly to blood 
cells, skin CD8+ T cells are composed of phenotypically distinct subsets. Indeed, differences 
between dermal and epidermal skin T cells have been reported previously 20. Epidermal CD8+ T cells 
in turn could be subdivided further into CD49a+ and CD49– cells, which had the ability to produce 
cytotoxic effector molecules or IL‐17, respectively 32. We show that skin resident T cells cannot 
simply be grouped into subsets using surface marker expression patterns that have been established 
using blood cells. Full identification, characterization and compartmentalization of all phenotypical 
and functional subsets of the skin T cells therefore remains outstanding.  
 
In summary, skin TRM CD8+ T cells have low cytotoxic potential unless they are stimulated either by 
cytokines such as IL‐15 or through the TCR. This, together with the negative regulation through PD‐
1, may be a mechanism that limits non‐specific tissue damage under homeostatic conditions. 
Importantly, skin CD8+ T cells are phenotypically and functionally distinct from circulating T cells and 
must not be categorized based on blood‐based surface markers, such as CD27 and CD45RA alone. 
The unique TRM subset diversity, including IL‐2/TNF‐α ‐producers, will require further exploration with 
this in mind.  
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Figure 1. Ex‐vivo CD69 expression and CD27/CD45RA differentiation subset distribution in 
CD8+ T cells derived from the blood and skin. Collagenase digested skin and peripheral blood 
mononuclear cells (PBMCs) were analysed via flow cytometry. (a) Representative gating strategy 
used to identify CD8+ T cells in both tissues derived from the same donor. (b) Representative 
histograms and (c) cumulative data showing expression of the tissue residence marker CD69 and 
CD103 (n = 8). (d) Immunofluorescence staining for CD8, CD69 and CD103 in a human skin section. 
(e) Representative flow cytometry staining for CD27 and CD45RA and (f) cumulative CD27/CD45RA 
subset distribution in blood and skin derived cells (n = 12). (G) CD69 expression by CD27/CD45RA 
subset in blood and skin cells. TCM = central memory, TEM = effector memory and TEMRA = effector 
memory re‐expressing CD45RA. 
 
Figure 2. Differentiation‐associated phenotypical properties of skin compared to blood CD8+ 
T cells. (a) Representative and (b) cumulative ex‐vivo measurements of CD28 (n = 6), receptor killer 
cell lectin like receptor G1 (KLRG1) (n = 9), and CD57 (n = 8), in CD8+ T cells and (c) in 
CD27/CD45RA subsets, measured via flow cytometry in collagenase digested skin and peripheral 
blood mononuclear cell (PBMC) samples derived from the same healthy donors. (d) KLRG1 
expression among CD69– and CD69+ skin cells (n = 19). (e) Cumulative data for total CD8+ T cells 
and T cell subsets for telomere length, measured via flow cytometry using the flow‐fluorescence in‐
situ hybridization (FISH) method on PBMCs and skin blister‐derived cells as described in the Material 
and methods section (n = 5). 
 
Figure 3. Interleukin (IL)‐2, interferon (IFN)‐γ and tumour necrosis factor (TNF)‐α cytokine 
production in blood and skin‐derived CD8+ T cells. Collagenase digested skin cells or peripheral 
blood mononuclear cells (PBMCs) were stimulated in vitro with phorbol myristate acetate 
(PMA)/ionomycin before intracellular flow cytometry was performed to detect cytokine production 
(n = 9). (a) Representative dot‐plots for IFN‐γ and TNF‐α staining. Histograms show IL‐2 production 
by different subsets based on IFN‐γ and TNF‐α production; (b) cumulative data for total CD8+ T cells 




producing IL‐2, IFN‐γ or TNF‐α alone or in combination. Cytokine production by different CD8 
subsets for (c) IL‐2/TNF‐α or (d) IL‐2/IFN‐γ/TNF‐α cytokine co‐production. 
 
Figure 4. Ex‐vivo expression of cytotoxic granule components in skin compared to blood 
CD8+ T cells. (a) Representative flow cytometry histograms and (b) cumulative data showing 
granzyme B and perforin expression in collagenase digested skin and blood derived CD8+ T cells 
from paired samples (n = 9). (c) Granzyme B and perforin expression among the CD8+ T cell subsets 
derived from blood (n = 33) and skin samples (n = 16). (D) Granzyme B and perforin expression in 
circulating CD8+ T cells positive or negative for the skin homing receptor cutaneous lymphocyte 
antigen (CLA) (n = 12). (e) Granzyme B and perforin expression in CD8+CD69/CD103 subsets in the 
skin of healthy donors (n = 3). (f) Expression of the transcription factors t‐bet or Eomes with 
granzyme B in skin and blood CD8+ T cells. 
 
Figure 5. Predictive value of CD27, CD28 and receptor killer cell lectin like receptor G1 
(KLRG1) surface expression for intracellular granzyme B in skin and blood CD8+ T cells. 
Representative dot plots and cumulative data showing (a) KLRG1, (b) CD27 and (c) CD28 
expression in relation to granzyme B expression in blood and skin‐derived CD8+ T cells. Graphs 
show the correlations between percentage CD27, CD28 or KLRG1 expression and percentage 
granzyme B expression (lines of best fit, r‐values and significance are shown where applicable). 
Further, cumulative data of granzyme B expression among CD27–/CD27+, CD28–/CD28+ and 
KLRG1+/KLRG1– (with averages and standard errors) are shown. KLRG1 was measured in 18 blood 
and nine skin donors; CD27 and CD28 were measured in 33 blood and 17 skin donors. 
 
Figure 6. Factors influencing granzyme B and perforin expression in blood and skin‐derived 
CD8+ T cells. Skin and blood‐derived cells from healthy donors were cultured for 4 days in the 
presence of tumour necrosis factor (TNF)‐α, interleukin (IL)‐2, IL‐15 or anti‐CD3/CD28, followed by 
intracellular flow cytometric staining. (a) Granzyme B and perforin expression [mean and standard 
error (s.e.)] in blood (n = 12) and skin‐derived cells (n = 10). (b) Representative and (c) cumulative 




data showing programmed cell death 1 (PD‐1) expression measured by flow cytometry. (d) 
Immunofluorescent staining of healthy skin for CD8, PD‐1 and nuclei [4′,6‐diamidino‐2‐phenylindole 
(DAPI)]. (e) Granzyme B and perforin expression following stimulation for 3 days with anti‐CD3 in 
the presence of programmed cell death ligand 1/2 (PDL‐1/2) blocking antibodies or isotype controls 













































Supporting figure legends. 
Figure S1: Ex‐vivo CD69 expression and CD27/CD45RA differentiation subset distribution in 
CD4+ T cells derived from the blood and skin. Collagenase digested skin and PBMCs were 
analyzed via flow cytometry. (a) Representative flow cytometry staining and (b) cumulative 
CD27/CD45RA subset distribution in blood and skin derived cells CD4+ T cells (n = 12). Expression 
of CD28 (n = 6), KLRG1 (n = 9) and CD57 (n = 8) among total blood and skin CD4+ T cells (c) and 
their subsets (d). (e) Skin cells or PBMCs were stimulated in vitro with PMA/Ionomycin before 
intracellular flow cytometry was performed to detect cytokine production. Cumulative data for total 
CD8+ T cells producing IL‐2, TNFα or IFNγ alone or in combination. 
 
Figure S2: Telomere length of skin and blood‐derived CD4+ T cells. (a) Representative gating 
strategy for blood and skin CD4+ and CD8+ T cell subset telomere length measurements. (b) 
Cumulative data for total CD4+ T cells and CD27/CD45RA subsets for telomere length, measured 
via flow cytometry using the Flow‐FISH method on PBMCs and skin blister derived cells as described 
in the material and methods section (n = 5). 
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